Alaska Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Sanofi (OP: SNYNF)
110.10 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News
Press releases about Sanofi
 
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Investment in a Québec public-private partnership to support the use of personalized medicine solutions in the treatment of cancer patients
February 15, 2013
from PR Newswire
Sanofi delivers solid 2012 results despite patent expirations
February 07, 2013
from PR Newswire
Sanofi FY 2012 - Interview with CEO Chris Viehbacher
February 07, 2013
from Business Wire News Releases
ZALTRAP® (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer
February 05, 2013
First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimen Read More
from PR Newswire
Zealand Pharma Announces Once-Daily Lyxumia(R) (lixisenatide) Approved in Europe for the Treatment of Type 2 Diabetes
February 04, 2013
Under the Agreement With Sanofi, the Company is Entitled to Tiered Low Double-Digit Percentage Royalties on Global Sales of Lyxumia(R) Read More
from GlobeNewswire News Releases
Genzyme and Isis Announce FDA Approval of KYNAMRO™ (mipomersen sodium) Injection for the Treatment of Homozygous Familial Hypercholesterolemia
January 29, 2013
from Business Wire News Releases
Football Legend Jerome Bettis and Cookbook Guru Robin Miller Kick-off Auvi-Q™ Anaphylaxis Awareness Campaign
January 29, 2013
- Bettis and Miller, Both at Risk for Anaphylaxis, Join Forces with Sanofi US to Introduce Auvi-Q (Epinephrine Injection, USP) and Serve Up Allergy-Friendly Tips for Big Game Parties - Read More
from PR Newswire
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
January 29, 2013
--LeGoo® proprietary gel technology provides clear surgical field for cardiothoracic and vascular surgeons without trauma to blood vessels-- Read More
from PR Newswire
Sanofi Announces Auvi-Q™, the First and Only Voice-Guided Epinephrine Auto-Injector, is Now Available in the U.S.
January 28, 2013
-- Breakthrough device design talks patients and caregivers through the injection process -- Read More
from PR Newswire
Genzyme’s LEMTRADA™ (alemtuzumab) Application for MS Accepted for Review by the FDA
January 28, 2013
from Business Wire News Releases
Allerject™ Canada's first 'talking' epinephrine auto-injector
January 25, 2013
from PR Newswire
NBA Family, American Diabetes Association, and Sanofi US Tip Off 2013 Dribble To Stop Diabetes Awareness Campaign
January 14, 2013
- NBA All-Stars Andre Iguodala and Danny Granger and Seven-Time WNBA All-Star Tamika Catchings to Help Raise Awareness about Diabetes - Read More
from PR Newswire
Sanofi's Chattem Acquires Over-the-Counter Antacid Rolaids®
January 07, 2013
-- Product acquisition further strengthens Consumer Healthcare Division of Sanofi US -- Read More
from PR Newswire
Sanofi US Reaches Settlement Agreement on Hyalgan
December 19, 2012
from PR Newswire
Genzyme and Isis Provide Update on CHMP Opinion on KYNAMRO™ (mipomersen)
December 14, 2012
from Business Wire News Releases
Sanofi US Announces Collaborate Activate Innovation Challenge Winner
December 12, 2012
- Registries for All Diseases wins $300k to create crowdsourced cross-disease registry - Read More
from PR Newswire
Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
December 09, 2012
- New Data Presented at American Society of Hematology Annual Meeting Show Activity Against Disease and Symptom Alleviation - Read More
from PR Newswire
Genzyme Receives European Label Expansion for Thyrogen
December 07, 2012
from Business Wire News Releases
STARsystem by Sanofi Canada Receives Digital Innovation Award
December 04, 2012
from PR Newswire
Selecta Biosciences and Sanofi Sign Global Collaboration to Develop Antigen-Specific Immunotherapies for up to Three Allergy Indications Based on Selecta’s Synthetic Vaccine Particle Technology
November 28, 2012
from Business Wire News Releases
Genzyme Honors Innovation in Gaucher Disease Research through Its 2012 Gaucher Generation Program Awards
November 26, 2012
from Business Wire News Releases
Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment of Relapsing Multiple Sclerosis
November 21, 2012
from Business Wire News Releases
Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
November 19, 2012
Response Includes Contribution to Three New Jersey Area Organizations Read More
from PR Newswire
Zealand Pharma Announces That Once-Daily Lyxumia(R)1 (Lixisenatide) Has Received CHMP Positive Opinion for the Treatment of Adults With Type 2 Diabetes in the EU
November 16, 2012
from GlobeNewswire News Releases
ZALTRAP® (ziv-aflibercept) Receives CHMP Positive Opinion in the European Union for Previously Treated Metastatic Colorectal Cancer
November 16, 2012
from PR Newswire
Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
November 14, 2012
from PR Newswire
Actress Elizabeth Perkins and Sanofi US Announce Nationwide Casting Call for Diabetes Co-Stars Documentary
November 14, 2012
from PR Newswire
Genzyme Announces Return to Full Supply of Thyrogen (thyrotropin alfa for injection)
November 13, 2012
from Business Wire News Releases
Sanofi and Genzyme Congratulate the 2012 Schwartz Center Compassionate Caregiver Award Winner
November 09, 2012
from Business Wire News Releases
Sanofi Pasteur Announces Publication of Pivotal Safety and Immunogenicity Data of Menactra® Vaccine for Infants and Toddlers
November 08, 2012
- Two-Dose Series Given at Regularly Scheduled Pediatric Visits Demonstrates Strong Immune Responses - Read More
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here